VACCINEX, INC.·4

Mar 19, 4:49 PM ET

Royer Scott E. 4

4 · VACCINEX, INC. · Filed Mar 19, 2019

Insider Transaction Report

Form 4
Period: 2019-03-15
Royer Scott E.
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-03-15+2,0002,000 total
    Exercise: $3.90Exp: 2029-03-14Common Stock (2,000 underlying)
Holdings
  • Common Stock

    3,999
  • Stock Option (Right to Buy)

    Exercise: $13.60Exp: 2028-02-21Common Stock (25,000 underlying)
    25,000
Footnotes (2)
  • [F1]This option initially vests in quarterly installments of 1,526 shares for each of four quarters beginning on May 21, 2018. The remainder vests in three equal annual installments beginning February 21, 2020.
  • [F2]This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 15, 2019 grant date.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT